China Medical System Holdings Limited (HKG:0867)
Hong Kong
· Delayed Price · Currency is HKD 12.94
-0.15 (-1.15%)
Apr 29, 2026, 1:43 PM HKT
HKG:0867 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 8,212 | 7,469 | 8,013 | 9,150 | 8,337 | Upgrade
|
| Revenue Growth (YoY) | 9.95% | -6.79% | -12.43% | 9.75% | 20.03% | Upgrade
|
| Cost of Revenue | 2,341 | 2,047 | 1,937 | 2,115 | 2,090 | Upgrade
|
| Gross Profit | 5,872 | 5,422 | 6,076 | 7,036 | 6,247 | Upgrade
|
| Selling, General & Admin | 3,708 | 3,442 | 3,168 | 3,358 | 2,981 | Upgrade
|
| Research & Development | 585.02 | 329.98 | 195.13 | 125.43 | 114.76 | Upgrade
|
| Operating Expenses | 4,293 | 3,772 | 3,363 | 3,483 | 3,096 | Upgrade
|
| Operating Income | 1,578 | 1,650 | 2,713 | 3,552 | 3,151 | Upgrade
|
| Interest Expense | -20.3 | -38.61 | -46.25 | -49.09 | -28.27 | Upgrade
|
| Interest & Investment Income | 82.35 | 126.34 | 177.1 | 105.52 | 81.85 | Upgrade
|
| Earnings From Equity Investments | 242.3 | 341.3 | 277.87 | 65.06 | 75.35 | Upgrade
|
| Currency Exchange Gain (Loss) | -12.84 | -53.15 | 31.54 | -126.21 | 22.62 | Upgrade
|
| Other Non Operating Income (Expenses) | 35.1 | 93.62 | -46.82 | 127.48 | 58.57 | Upgrade
|
| EBT Excluding Unusual Items | 1,905 | 2,120 | 3,106 | 3,675 | 3,361 | Upgrade
|
| Impairment of Goodwill | - | - | - | -60 | -20 | Upgrade
|
| Gain (Loss) on Sale of Investments | 210.99 | -109.03 | -60.75 | 150.01 | 115.66 | Upgrade
|
| Gain (Loss) on Sale of Assets | 18.73 | 0.5 | -0.27 | -0.4 | -0.23 | Upgrade
|
| Asset Writedown | -31.74 | -1.15 | -171.49 | -2 | - | Upgrade
|
| Pretax Income | 2,103 | 2,010 | 2,874 | 3,763 | 3,457 | Upgrade
|
| Income Tax Expense | 659.78 | 397.23 | 489.34 | 486.66 | 431.33 | Upgrade
|
| Earnings From Continuing Operations | 1,443 | 1,613 | 2,384 | 3,276 | 3,025 | Upgrade
|
| Minority Interest in Earnings | 45.62 | 6.71 | 16.51 | -17.2 | -7.86 | Upgrade
|
| Net Income | 1,489 | 1,620 | 2,401 | 3,259 | 3,017 | Upgrade
|
| Net Income to Common | 1,489 | 1,620 | 2,401 | 3,259 | 3,017 | Upgrade
|
| Net Income Growth | -8.08% | -32.53% | -26.33% | 8.01% | 19.25% | Upgrade
|
| Shares Outstanding (Basic) | 2,420 | 2,427 | 2,452 | 2,454 | 2,468 | Upgrade
|
| Shares Outstanding (Diluted) | 2,420 | 2,427 | 2,452 | 2,454 | 2,468 | Upgrade
|
| Shares Change (YoY) | -0.32% | -1.00% | -0.08% | -0.56% | -0.17% | Upgrade
|
| EPS (Basic) | 0.62 | 0.67 | 0.98 | 1.33 | 1.22 | Upgrade
|
| EPS (Diluted) | 0.62 | 0.67 | 0.98 | 1.33 | 1.22 | Upgrade
|
| EPS Growth | -7.78% | -31.85% | -26.27% | 8.61% | 19.45% | Upgrade
|
| Free Cash Flow | 717.38 | 1,236 | 2,475 | 3,535 | 2,471 | Upgrade
|
| Free Cash Flow Per Share | 0.30 | 0.51 | 1.01 | 1.44 | 1.00 | Upgrade
|
| Dividend Per Share | 0.292 | 0.268 | 0.392 | 0.534 | 0.491 | Upgrade
|
| Dividend Growth | 8.95% | -31.55% | -26.70% | 8.84% | 18.66% | Upgrade
|
| Gross Margin | 71.50% | 72.60% | 75.82% | 76.89% | 74.93% | Upgrade
|
| Operating Margin | 19.22% | 22.10% | 33.85% | 38.82% | 37.80% | Upgrade
|
| Profit Margin | 18.13% | 21.69% | 29.96% | 35.62% | 36.19% | Upgrade
|
| Free Cash Flow Margin | 8.74% | 16.55% | 30.89% | 38.63% | 29.63% | Upgrade
|
| EBITDA | 1,825 | 1,886 | 2,922 | 3,762 | 3,357 | Upgrade
|
| EBITDA Margin | 22.22% | 25.25% | 36.47% | 41.11% | 40.27% | Upgrade
|
| D&A For EBITDA | 246.34 | 235.74 | 209.3 | 209.08 | 206.05 | Upgrade
|
| EBIT | 1,578 | 1,650 | 2,713 | 3,552 | 3,151 | Upgrade
|
| EBIT Margin | 19.22% | 22.10% | 33.85% | 38.82% | 37.80% | Upgrade
|
| Effective Tax Rate | 31.37% | 19.76% | 17.03% | 12.93% | 12.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.